Different stresses, such as cancer treatment, trigger cardiac fibrosis, leading to heart failure and death. In the US, there are 18M cancer survivors, and 10% of them will develop cardiac fibrosis because of their treatment.
We have developed a patented cell-based therapy that recognizes and eliminates the driver of the disease; our preclinical studies show recovery of heart function following treatment.
